NCCN Guidelines™ and NCCN Compendium™ Updated
Flash Update Sent May 24, 2012
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Soft Tissue Sarcoma. These NCCN Guidelines® are currently available as Version 2.2012.
- A section on recommendations (including systemic therapy options) for the management of patients with Rhabdomyosarcoma was added.
- Systemic Therapy Agents and Regimens with Activity in Soft Tissue Sarcoma
- A new footnote was added for "Temozolomide" and "Pazopanib" that states, "Recommended only for palliative therapy."
- The Discussion section has been updated to reflect the changes in the algorithm.
For the complete updated versions of the NCCN Guidelines™ and the NCCN Compendium™ please visit NCCN.org.